Alltracel shares up 6% on major deals

SHARES in Alltracel Pharmaceuticals rose by 6% yesterday after the fledgling Dublin-based first aid product developer announced two major deals with leading names in the industry.

The company said it had started shipping its new treatment for shaving cuts to British pharmacy heavyweight Boots. Under the terms of the agreement, Boots will begin selling Alltracel’s Blotters product this week.

Blotters are thin strips of film that contain an anti-bleeding agent developed by Alltracel. The strips form a gel-like layer over a cut when they come into contact with blood.